Published on in Vol 3, No 2 (2020): Jul-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/25607, first published .
Secondary Prevention of Hip Fragility Fractures During the COVID-19 Pandemic: Service Evaluation of “MRS BAD BONES”

Secondary Prevention of Hip Fragility Fractures During the COVID-19 Pandemic: Service Evaluation of “MRS BAD BONES”

Secondary Prevention of Hip Fragility Fractures During the COVID-19 Pandemic: Service Evaluation of “MRS BAD BONES”

Journals

  1. Hampson G, Stone M, Lindsay J, Crowley R, Ralston S. Diagnosis and Management of Osteoporosis During COVID-19: Systematic Review and Practical Guidance. Calcified Tissue International 2021;109(4):351 View
  2. Kong S, Hwang B, Yoon B. The Impact of COVID-19 on the Optimal Management of Osteoporosis. Journal of Bone Metabolism 2021;28(2):115 View
  3. Moretti A, Liguori S, Paoletta M, Migliaccio S, Toro G, Gimigliano F, Iolascon G. Bone fragility during the COVID-19 pandemic: the role of macro- and micronutrients. Therapeutic Advances in Musculoskeletal Disease 2023;15:1759720X2311582 View
  4. Rattanakitkoson T, Chinvattanachot G, Piyapromdee U. IMPACT OF THE COVID-19 PANDEMIC ON FRAGILITY HIP FRACTURE MANAGEMENT AND MORTALITY RATE. Journal of Southeast Asian Medical Research 2023;7:e0155 View